Cholinergic Markers in Children with and without Autism and Fragile X Syndrome



Study Overview

The purpose of this study is to determine if children with autism and Fragile X Syndrome (FXS) have abnormal levels of cholinergic markers as compared to children without autism or FXS.


Study Description

The purpose of this study is to determine if children with autism and Fragile X Syndrome (FXS) have abnormal levels of cholinergic markers as compared to children without autism or FXS.

Additional Information:

Participants will be paid for their participation.



Research Study Identifier: TX1600
ClinicalTrials.gov Identifier: NCT1105005650
Principal Investigator: Deborah Sokol


Currently Recruiting

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.